CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
License revenue		$ 375		$ 1,125
Operating expenses:
Research and development	$ 12,102	10,077	$ 33,931	24,090
General and administrative	3,186	2,438	8,889	7,973
Total operating expenses	15,288	12,515	42,820	32,063
Loss from operations	(15,288)	(12,140)	(42,820)	(30,938)
Interest income	360	1	404	4
Interest expense	(11)	(9)	(49)	(39)
Australian research and development incentives	652	1,269	1,276	1,584
Foreign currency loss	(807)	(260)	(1,305)	(410)
Net loss attributable to common stockholders	$ (15,094)	$ (11,139)	$ (42,494)	$ (29,799)
Net loss per share
Basic	$ (0.13)	$ (0.14)	$ (0.38)	$ (0.39)
Diluted	$ (0.13)	$ (0.14)	$ (0.38)	$ (0.39)
Weighted average common shares outstanding
Basic	113,239,092	78,218,774	113,239,092	76,631,172
Diluted	113,239,092	78,218,774	113,239,092	76,631,172